Gerald R. Fink, Ph.D. ’65, American Cancer Society Professor of Genetics at the Massachusetts Institute of Technology (MIT) and former director and founding member of the Whitehead Institute, has joined the scientific advisory board of Dyadic International, a biotechnology company that bases its products and solutions on its protein expression technology.
Previous Article
1940s - Wessel
Next Article
Sally Provence’s autism work deserves mention